title: Vancomycin-resistant enterococci: risk related to the use of intravenous vancomycin in a university hospital.
authors.forename: R E
authors.initials: RE
authors.lastname: Fuller
authors.forename: L J
authors.initials: LJ
authors.lastname: Harrell
authors.forename: F T
authors.initials: FT
authors.lastname: Meredith
authors.forename: D J
authors.initials: DJ
authors.lastname: Sexton
authors.forename: L G
authors.initials: LG
authors.lastname: Colvin
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D000900:Anti-Bacterial Agents / Q000008:administration & dosage*; D015331:Cohort Studies; D003428:Cross Infection / Q000453:epidemiology* / Q000635:transmission*; D004352:Drug Resistance, Microbial; D016983:Enterococcus / Q000187:drug effects / Q000302:isolation & purification*; D005260:Female; D006785:Hospitals, University; D006801:Humans; D015994:Incidence; D007262:Infusions, Intravenous; D008297:Male; D008875:Middle Aged; D009657:North Carolina / Q000453:epidemiology; D011446:Prospective Studies; D012306:Risk; D012307:Risk Factors; D014640:Vancomycin / Q000008:administration & dosage*
chemical_list: D000900:Anti-Bacterial Agents; D014640:Vancomycin